Cas:1131587-88-6 methyl 5-bromo-2-pyrrolidin-1-ylbenzoate manufacturer & supplier

We serve Chemical Name:methyl 5-bromo-2-pyrrolidin-1-ylbenzoate CAS:1131587-88-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 5-bromo-2-pyrrolidin-1-ylbenzoate

Chemical Name:methyl 5-bromo-2-pyrrolidin-1-ylbenzoate
CAS.NO:1131587-88-6
Synonyms:methyl 5-bromo-2-(pyrrolidin-1-yl)benzoate;methyl 5-bromanyl-2-pyrrolidin-1-yl-benzoate
Molecular Formula:C12H14BrNO2
Molecular Weight:284.14900
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.54000
Exact Mass:283.02100
LogP:2.90090

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 5-bromo-2-(pyrrolidin-1-yl)benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 5-bromanyl-2-pyrrolidin-1-yl-benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 5-bromanyl-2-pyrrolidin-1-yl-benzoate Use and application,methyl 5-bromo-2-(pyrrolidin-1-yl)benzoate technical grade,usp/ep/jp grade.


Related News: Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’. methyl 5-bromo-2-pyrrolidin-1-ylbenzoate manufacturer Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’. methyl 5-bromo-2-pyrrolidin-1-ylbenzoate supplier Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. methyl 5-bromo-2-pyrrolidin-1-ylbenzoate vendor Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. methyl 5-bromo-2-pyrrolidin-1-ylbenzoate factory Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.